Compare Cipta Sarana Medika Tbk. (DKHH) vs Reksa Dana Indeks Mandiri ETF LQ45 (XMLF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cipta Sarana Medika Tbk. vs Reksa Dana Indeks Mandiri ETF LQ45 — how do they compare? Cipta Sarana Medika Tbk. trades at Rp64 (market cap 163.22B, 3.92M 24h volume), while Reksa Dana Indeks Mandiri ETF LQ45 trades at Rp725 (market cap 9.29B, 700 24h volume). The key difference: Cipta Sarana Medika Tbk. is far larger — about 17.6× Reksa Dana Indeks Mandiri ETF LQ45's market cap, and Cipta Sarana Medika Tbk. is more actively traded (3.92M versus 700). Which is the better fit depends on your goals.
| DKHH | XMLF | |
|---|---|---|
Market Cap | 163.22B | 9.29B |
Volume | 3.92M | 700 |
Lot | 39.16K | 7 |
Turnover | 249.6M | 507.5K |
Average Price | 63.74 | 725 |
Value | 249.6M | 507.5K |
Indicative Equilibrium Price | 64 | — |
Indicative Equilibrium Volume | 77 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cipta Sarana Medika Tbk.
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →
